Get the Stockscreener App
105.16
1.28%
-1.71
Zimmer Biomet Holdings Inc stock is traded at $105.16, with a volume of 24,308.
It is down -1.28% in the last 24 hours and down -5.88% over the past month.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
See More
Previous Close:
$106.87
Open:
$106.05
24h Volume:
24,308
Relative Volume:
0.02
Market Cap:
$21.28B
Revenue:
$7.60B
Net Income/Loss:
$1.08B
P/E Ratio:
43.63
EPS:
2.41
Net Cash Flow:
$1.26B
1W Performance:
-1.23%
1M Performance:
-5.88%
6M Performance:
-2.79%
1Y Performance:
-13.31%
1-Day Range:
$105.00
$106.35
1-Week Range:
$105.00
$108.12
52-Week Range:
$101.47
$133.90
Zimmer Biomet Holdings Inc Stock (ZBH) Company Profile
Name
Zimmer Biomet Holdings Inc
Sector
Industry
Phone
(574) 267-6131
Address
345 EAST MAIN STREET, WARSAW, IN
Compare ZBH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ZBH
Zimmer Biomet Holdings Inc
|
105.41 | 21.28B | 7.60B | 1.08B | 1.26B | 5.26 |
|
ABT
Abbott Laboratories
|
113.03 | 199.45B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
360.64 | 139.95B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
89.11 | 133.62B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
79.64 | 103.53B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
74.54 | 44.62B | 6.60B | 4.16B | 490.10M | 6.93 |
Zimmer Biomet Holdings Inc Stock (ZBH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-17-24 | Upgrade | JP Morgan | Neutral → Overweight |
| Sep-10-24 | Initiated | Wolfe Research | Peer Perform |
| Jul-01-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-30-24 | Initiated | Goldman | Neutral |
| May-21-24 | Upgrade | Argus | Hold → Buy |
| Jan-04-24 | Downgrade | Evercore ISI | Outperform → In-line |
| Oct-20-23 | Initiated | ROTH MKM | Neutral |
| Aug-28-23 | Upgrade | BTIG Research | Neutral → Buy |
| May-03-23 | Upgrade | BofA Securities | Underperform → Neutral |
| Apr-11-23 | Upgrade | Evercore ISI | In-line → Outperform |
| Mar-31-23 | Upgrade | Jefferies | Underperform → Hold |
| Mar-29-23 | Initiated | UBS | Sell |
| Mar-10-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jan-09-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Jan-05-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Nov-23-22 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-18-22 | Initiated | Barclays | Underweight |
| Oct-12-22 | Initiated | Jefferies | Underperform |
| May-27-22 | Downgrade | Needham | Buy → Hold |
| Apr-13-22 | Downgrade | Truist | Buy → Hold |
| Apr-01-22 | Downgrade | Citigroup | Buy → Neutral |
| Mar-02-22 | Resumed | BofA Securities | Underperform |
| Mar-02-22 | Downgrade | Loop Capital | Buy → Hold |
| Feb-08-22 | Downgrade | Canaccord Genuity | Buy → Hold |
| Feb-08-22 | Reiterated | Citigroup | Buy |
| Feb-08-22 | Reiterated | Deutsche Bank | Hold |
| Feb-08-22 | Reiterated | JMP Securities | Mkt Outperform |
| Feb-08-22 | Reiterated | JP Morgan | Neutral |
| Feb-08-22 | Reiterated | RBC Capital Mkts | Sector Perform |
| Feb-08-22 | Reiterated | Stifel | Buy |
| Feb-08-22 | Reiterated | Truist | Buy |
| Feb-08-22 | Reiterated | UBS | Neutral |
| Feb-08-22 | Reiterated | Wells Fargo | Underweight |
| Feb-02-22 | Downgrade | UBS | Buy → Neutral |
| Jan-19-22 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Jan-10-22 | Downgrade | Mizuho | Buy → Neutral |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-04-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-10-21 | Initiated | RBC Capital Mkts | Sector Perform |
| Dec-09-21 | Downgrade | Needham | Strong Buy → Buy |
| Dec-07-21 | Initiated | Loop Capital | Buy |
| Nov-23-21 | Downgrade | Argus | Buy → Hold |
| Sep-14-21 | Resumed | Raymond James | Mkt Perform |
| May-25-21 | Initiated | Barclays | Overweight |
| Apr-09-21 | Upgrade | Northland Capital | Market Perform → Outperform |
| Jan-04-21 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-18-20 | Reiterated | Needham | Strong Buy |
| Oct-20-20 | Initiated | Northland Capital | Market Perform |
| Sep-11-20 | Initiated | Wolfe Research | Outperform |
| Aug-05-20 | Reiterated | Needham | Strong Buy |
| Apr-28-20 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-09-20 | Downgrade | Evercore ISI | Outperform → In-line |
| Apr-07-20 | Reiterated | Needham | Strong Buy |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Buy |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Jan-07-20 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Jan-07-20 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-04-19 | Upgrade | Raymond James | Outperform → Strong Buy |
| Oct-07-19 | Upgrade | BTIG Research | Neutral → Buy |
| Sep-18-19 | Upgrade | Canaccord Genuity | Hold → Buy |
| Aug-12-19 | Upgrade | Argus | Hold → Buy |
| Jul-30-19 | Upgrade | Barclays | Underweight → Equal Weight |
| Jul-29-19 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jun-11-19 | Upgrade | Bernstein | Underperform → Mkt Perform |
| Apr-24-19 | Upgrade | Needham | Buy → Strong Buy |
View All
Zimmer Biomet Holdings Inc Stock (ZBH) Latest News
ZIMMER BIOMET HOLDINGS, INC. - Marketscreener.com
Zimmer Biomet: The Valuation Discount Is Not Justified - Yahoo Finance
Biomet Hip Lawsuit Filed Over Defective M2A Metal-on-Metal Implant - AboutLawsuits.com
ZBH Stock to Benefit From Global Expansion Despite Macro Issues - Yahoo Finance
Zimmer Biomet Holdings (NYSE:ZBH) Could Be A Buy For Its Upcoming Dividend - Simply Wall St
Zimmer Biomet Holdings Inc. stock rises Tuesday, still underperforms market - MarketWatch
Zimmer Biomet Holdings (NYSE:ZBH) Is Due To Pay A Dividend Of $0.24 - Simply Wall St
Zimmer Biomet to Present at the 43rd Annual J.P. Morgan Healthcare Conference - Kilgore News Herald
Zimmer Biomet Announces Quarterly Dividend for Third Quarter of 2024 - The Eastern Progress Online
Zimmer Biomet to Present at the 43rd Annual J.P. Morgan Healthca - GuruFocus.com
Zimmer Biomet to Present at the 43rd Annual J.P. Morgan Healthcare Conference – Company Announcement - Financial Times
How Is Zimmer Biomet Holdings' Stock Performance Compared to Other Medical Device Stocks? - MSN
Zimmer Biomet receives FDA 510(k) clearance for stemless total shoulder replacement system - Healio
Zimmer Biomet Holdings Inc. stock outperforms competitors despite losses on the day - MarketWatch
Zimmer Biomet price target raised to $118 from $117 at Truist - Yahoo Finance
Zimmer Biomet Announces Quarterly Dividend for Fourth Quarter of 2024 - The Malaysian Reserve
Total Wrist Replacement Market Top PlayersZimmer Biomet, - openPR
Zimmer Biomet sets quarterly dividend for Q4 2024 By Investing.com - Investing.com Australia
Zimmer Biomet Holdings Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Zimmer Biomet (NYSE:ZBH) Given New $118.00 Price Target at Truist Financial - MarketBeat
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Declares Quarterly Dividend of $0.24 - MarketBeat
Zimmer Biomet Holdings (NYSE:ZBH) shareholders have endured a 23% loss from investing in the stock five years ago - Yahoo Finance
Zimmer Biomet Holdings, Inc. Announces Quarterly Cash Dividend for Fourth Quarter of 2024, Payable on or About January 31, 2025 - Marketscreener.com
Zimmer Biomet sets quarterly dividend for Q4 2024 - Investing.com India
Spine Surgery Devices Market to See Booming Growth 2024-2031 | - openPR
JP Morgan Upgrades Zimmer Biomet Holdings (ZBH) - MSN
Zimmer Biomet Holdings Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
JPMorgan Chase & Co. Upgrades Zimmer Biomet (NYSE:ZBH) to Overweight - MarketBeat
Orthopaedic Implants Market Research with Growth Forecasts - GlobeNewswire
Orthopaedic Implants Market Research with Growth Forecasts to 2029: Industry Dominated by Stryker Corporation, Zimmer Biomet, Johnson & Johnson MedTech, Smith+Nephew, and B. Braun - Yahoo Finance UK
Franklin Resources Inc. Cuts Stock Position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Zimmer Biomet Holdings Inc. stock rises Monday, still underperforms market - MarketWatch
Zimmer receives FDA nod for stemless shoulder implant - Yahoo Finance
Zimmer Biomet’s total shoulder replacement system gains FDA 510(k) clearance - Yahoo Finance
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Shares Purchased by Toronto Dominion Bank - MarketBeat
Zimmer Biomet's SWOT analysis: stock outlook amid ERP challenges, growth targets - Investing.com
M&T Bank Corp Raises Holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Zimmer Biomet to Present at Citi's 2024 Global Healthcare Conference - The Eastern Progress Online
Zimmer Biomet Holdings Inc. stock underperforms Friday when compared to competitors - MarketWatch
Zimmer Biomet Receives FDA Clearance for OsseoFit™ Stemless Shoulder System for Total Shoulder Replacement - BioSpace
Zimmer Biomet wins FDA nod for stemless shoulder system - Mass Device
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Shares Sold by Virtu Financial LLC - MarketBeat
Geode Capital Management LLC Has $524.94 Million Position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Shares Sold by Public Employees Retirement System of Ohio - MarketBeat
Verition Fund Management LLC Reduces Stake in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Zimmer Biomet Secures FDA Clearance for Revolutionary Stemless Shoulder Replacement System - StockTitan
Zimmer Biomet to Present at the Wells Fargo 2024 and Morgan Stanley Annual Global Healthcare Conferences - The Eastern Progress Online
2 Robotic Surgery Stocks Challenging Intuitive Surgical's Lead - MarketBeat
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Shares Sold by Stifel Financial Corp - MarketBeat
Zimmer Biomet Announces Webcast and Conference Call of Third Quarter 2024 Financial Results - The Eastern Progress Online
Zimmer Biomet Holdings Inc Stock (ZBH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.96%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):